Literature DB >> 28232621

Eculizumab: another breakthrough.

Robert A Brodsky1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28232621     DOI： 10.1182/blood-2017-01-760496

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.

Authors:  Austin G Kulasekararaj; Anita Hill; Saskia Langemeijer; Richard Wells; F Ataúlfo González Fernández; Anna Gaya; Emilio Ojeda Gutierrez; Caroline I Piatek; Lindsay Mitchell; Kensuke Usuki; Alberto Bosi; Robert A Brodsky; Masayo Ogawa; Ji Yu; Stephan Ortiz; Alexander Röth; Jong Wook Lee; Régis Peffault de Latour
Journal:  Eur J Haematol       Date:  2021-01-03       Impact factor: 2.997

2.  Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.

Authors:  Chloe R McDonald; Lindsay S Cahill; Joel L Gamble; Robyn Elphinstone; Lisa M Gazdzinski; Kathleen J Y Zhong; Adrienne C Philson; Mwayiwawo Madanitsa; Linda Kalilani-Phiri; Victor Mwapasa; Feiko O Ter Kuile; John G Sled; Andrea L Conroy; Kevin C Kain
Journal:  Sci Transl Med       Date:  2018-03-07       Impact factor: 17.956

3.  Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.

Authors:  Régis Peffault de Latour; Robert A Brodsky; Stephan Ortiz; Antonio M Risitano; Jun H Jang; Peter Hillmen; Alexander D Kulagin; Austin G Kulasekararaj; Scott T Rottinghaus; Rasha Aguzzi; Xiang Gao; Richard A Wells; Jeff Szer
Journal:  Br J Haematol       Date:  2020-05-24       Impact factor: 6.998

4.  One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.

Authors:  Hubert Schrezenmeier; Austin Kulasekararaj; Lindsay Mitchell; Flore Sicre de Fontbrune; Timothy Devos; Shinichiro Okamoto; Richard Wells; Scott T Rottinghaus; Peng Liu; Stephan Ortiz; Jong Wook Lee; Gérard Socié
Journal:  Ther Adv Hematol       Date:  2020-10-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.